Lucid Diagnostics Inc.
LUCD
$1.01
$0.022.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -16.49% | 24.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.49% | 24.19% | |||
| Cost of Revenue | -12.63% | 9.61% | |||
| Gross Profit | -3.65% | 26.75% | |||
| SG&A Expenses | -11.78% | 19.51% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.83% | 19.62% | |||
| Operating Income | 13.54% | -19.15% | |||
| Income Before Tax | 14.49% | -56.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.49% | -56.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.49% | -56.45% | |||
| EBIT | 13.54% | -19.15% | |||
| EBITDA | 13.84% | -19.61% | |||
| EPS Basic | -36.27% | -28.82% | |||
| Normalized Basic EPS | 18.73% | 1.78% | |||
| EPS Diluted | -36.27% | -28.82% | |||
| Normalized Diluted EPS | 18.73% | 1.78% | |||
| Average Basic Shares Outstanding | 6.62% | 21.46% | |||
| Average Diluted Shares Outstanding | 6.62% | 21.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||